Selected research
Industry Research
Clinical Pathology Service Industry Research Report 2026
Market perspective
The global Clinical Pathology Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Clinical Pathology Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Clinical Pathology Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Clinical Pathology Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Clinical Pathology Service include Charles River Laboratories, Clinical Pathology Laboratories, Healius, Incyte Diagnostics, Labcorp, LMC Pathology Services, Mayo Clinic Laboratories, Oculus Pathology and PathGroup, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Clinical Pathology Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Clinical Pathology Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Clinical Pathology Service Market by Company
Charles River Laboratories
Clinical Pathology Laboratories
Healius
Incyte Diagnostics
Labcorp
LMC Pathology Services
Mayo Clinic Laboratories
Oculus Pathology
PathGroup
Unilabs
Precision for Medicine
Sonic Healthcare
StrataDx
Sutter Health
AmeriPath
Biogenex
Cerba HealthCare Group
Clinical Pathology Service Segment by Type
Screening and Early Diagnosis Service
Confirmation and Subtyping Diagnosis Service
Treatment Guidance and Prognosis Service
Efficacy Monitoring Service
Others
Clinical Pathology Service Segment by Application
Disease Diagnosis and Differential Diagnosis
Treatment Decision-Making and Regimen Development
Efficacy Evaluation and Prognosis
Disease Screening and Early Prevention
Clinical Pathology Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Clinical Pathology Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Clinical Pathology Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Clinical Pathology Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Clinical Pathology Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Screening and Early Diagnosis Service
- Confirmation and Subtyping Diagnosis Service
- Treatment Guidance and Prognosis Service
- Efficacy Monitoring Service
- Others
Applications
- Disease Diagnosis and Differential Diagnosis
- Treatment Decision-Making and Regimen Development
- Efficacy Evaluation and Prognosis
- Disease Screening and Early Prevention
Companies covered
- Charles River Laboratories
- Clinical Pathology Laboratories
- Healius
- Incyte Diagnostics
- Labcorp
- LMC Pathology Services
- Mayo Clinic Laboratories
- Oculus Pathology
- PathGroup
- Unilabs
- Precision for Medicine
- Sonic Healthcare
- StrataDx
- Sutter Health
- AmeriPath
- Biogenex
- Cerba HealthCare Group
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Clinical Pathology Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Screening and Early Diagnosis Service
- 2.2.3 Confirmation and Subtyping Diagnosis Service
- 2.2.4 Treatment Guidance and Prognosis Service
- 2.2.5 Efficacy Monitoring Service
- 2.2.6 Others
- 2.3 Clinical Pathology Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Disease Diagnosis and Differential Diagnosis
- 2.3.3 Treatment Decision-Making and Regimen Development
- 2.3.4 Efficacy Evaluation and Prognosis
- 2.3.5 Disease Screening and Early Prevention
- 2.4 Assumptions and Limitations
3 Clinical Pathology Service Breakdown Data by Type
- 3.1 Global Clinical Pathology Service Historic Market Size by Type (2021-2026)
- 3.2 Global Clinical Pathology Service Forecasted Market Size by Type (2027-2032)
4 Clinical Pathology Service Breakdown Data by Application
- 4.1 Global Clinical Pathology Service Historic Market Size by Application (2021-2026)
- 4.2 Global Clinical Pathology Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Clinical Pathology Service Market Perspective (2021-2032)
- 5.2 Global Clinical Pathology Service Growth Trends by Region
- 5.2.1 Global Clinical Pathology Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Clinical Pathology Service Historic Market Size by Region (2021-2026)
- 5.2.3 Clinical Pathology Service Forecasted Market Size by Region (2027-2032)
- 5.3 Clinical Pathology Service Market Dynamics
- 5.3.1 Clinical Pathology Service Industry Trends
- 5.3.2 Clinical Pathology Service Market Drivers
- 5.3.3 Clinical Pathology Service Market Challenges
- 5.3.4 Clinical Pathology Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Clinical Pathology Service Players by Revenue
- 6.1.1 Global Top Clinical Pathology Service Players by Revenue (2021-2026)
- 6.1.2 Global Clinical Pathology Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Clinical Pathology Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Clinical Pathology Service Head Office and Area Served
- 6.4 Global Clinical Pathology Service Players, Product Type & Application
- 6.5 Global Clinical Pathology Service Manufacturers Established Date
- 6.6 Global Clinical Pathology Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Clinical Pathology Service Market Size (2021-2032)
- 7.2 North America Clinical Pathology Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Clinical Pathology Service Market Size by Country (2021-2026)
- 7.4 North America Clinical Pathology Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Clinical Pathology Service Market Size (2021-2032)
- 8.2 Europe Clinical Pathology Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Clinical Pathology Service Market Size by Country (2021-2026)
- 8.4 Europe Clinical Pathology Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Clinical Pathology Service Market Size (2021-2032)
- 9.2 Asia-Pacific Clinical Pathology Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Clinical Pathology Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Clinical Pathology Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Clinical Pathology Service Market Size (2021-2032)
- 10.2 South America Clinical Pathology Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Clinical Pathology Service Market Size by Country (2021-2026)
- 10.4 South America Clinical Pathology Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Clinical Pathology Service Market Size (2021-2032)
- 11.2 Middle East & Africa Clinical Pathology Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Clinical Pathology Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Clinical Pathology Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Charles River Laboratories
- 12.1.1 Charles River Laboratories Company Information
- 12.1.2 Charles River Laboratories Business Overview
- 12.1.3 Charles River Laboratories Revenue in Clinical Pathology Service Business (2021-2026)
- 12.1.4 Charles River Laboratories Clinical Pathology Service Product Portfolio
- 12.1.5 Charles River Laboratories Recent Developments
- 12.2 Clinical Pathology Laboratories
- 12.2.1 Clinical Pathology Laboratories Company Information
- 12.2.2 Clinical Pathology Laboratories Business Overview
- 12.2.3 Clinical Pathology Laboratories Revenue in Clinical Pathology Service Business (2021-2026)
- 12.2.4 Clinical Pathology Laboratories Clinical Pathology Service Product Portfolio
- 12.2.5 Clinical Pathology Laboratories Recent Developments
- 12.3 Healius
- 12.3.1 Healius Company Information
- 12.3.2 Healius Business Overview
- 12.3.3 Healius Revenue in Clinical Pathology Service Business (2021-2026)
- 12.3.4 Healius Clinical Pathology Service Product Portfolio
- 12.3.5 Healius Recent Developments
- 12.4 Incyte Diagnostics
- 12.4.1 Incyte Diagnostics Company Information
- 12.4.2 Incyte Diagnostics Business Overview
- 12.4.3 Incyte Diagnostics Revenue in Clinical Pathology Service Business (2021-2026)
- 12.4.4 Incyte Diagnostics Clinical Pathology Service Product Portfolio
- 12.4.5 Incyte Diagnostics Recent Developments
- 12.5 Labcorp
- 12.5.1 Labcorp Company Information
- 12.5.2 Labcorp Business Overview
- 12.5.3 Labcorp Revenue in Clinical Pathology Service Business (2021-2026)
- 12.5.4 Labcorp Clinical Pathology Service Product Portfolio
- 12.5.5 Labcorp Recent Developments
- 12.6 LMC Pathology Services
- 12.6.1 LMC Pathology Services Company Information
- 12.6.2 LMC Pathology Services Business Overview
- 12.6.3 LMC Pathology Services Revenue in Clinical Pathology Service Business (2021-2026)
- 12.6.4 LMC Pathology Services Clinical Pathology Service Product Portfolio
- 12.6.5 LMC Pathology Services Recent Developments
- 12.7 Mayo Clinic Laboratories
- 12.7.1 Mayo Clinic Laboratories Company Information
- 12.7.2 Mayo Clinic Laboratories Business Overview
- 12.7.3 Mayo Clinic Laboratories Revenue in Clinical Pathology Service Business (2021-2026)
- 12.7.4 Mayo Clinic Laboratories Clinical Pathology Service Product Portfolio
- 12.7.5 Mayo Clinic Laboratories Recent Developments
- 12.8 Oculus Pathology
- 12.8.1 Oculus Pathology Company Information
- 12.8.2 Oculus Pathology Business Overview
- 12.8.3 Oculus Pathology Revenue in Clinical Pathology Service Business (2021-2026)
- 12.8.4 Oculus Pathology Clinical Pathology Service Product Portfolio
- 12.8.5 Oculus Pathology Recent Developments
- 12.9 PathGroup
- 12.9.1 PathGroup Company Information
- 12.9.2 PathGroup Business Overview
- 12.9.3 PathGroup Revenue in Clinical Pathology Service Business (2021-2026)
- 12.9.4 PathGroup Clinical Pathology Service Product Portfolio
- 12.9.5 PathGroup Recent Developments
- 12.10 Unilabs
- 12.10.1 Unilabs Company Information
- 12.10.2 Unilabs Business Overview
- 12.10.3 Unilabs Revenue in Clinical Pathology Service Business (2021-2026)
- 12.10.4 Unilabs Clinical Pathology Service Product Portfolio
- 12.10.5 Unilabs Recent Developments
- 12.11 Precision for Medicine
- 12.11.1 Precision for Medicine Company Information
- 12.11.2 Precision for Medicine Business Overview
- 12.11.3 Precision for Medicine Revenue in Clinical Pathology Service Business (2021-2026)
- 12.11.4 Precision for Medicine Clinical Pathology Service Product Portfolio
- 12.11.5 Precision for Medicine Recent Developments
- 12.12 Sonic Healthcare
- 12.12.1 Sonic Healthcare Company Information
- 12.12.2 Sonic Healthcare Business Overview
- 12.12.3 Sonic Healthcare Revenue in Clinical Pathology Service Business (2021-2026)
- 12.12.4 Sonic Healthcare Clinical Pathology Service Product Portfolio
- 12.12.5 Sonic Healthcare Recent Developments
- 12.13 StrataDx
- 12.13.1 StrataDx Company Information
- 12.13.2 StrataDx Business Overview
- 12.13.3 StrataDx Revenue in Clinical Pathology Service Business (2021-2026)
- 12.13.4 StrataDx Clinical Pathology Service Product Portfolio
- 12.13.5 StrataDx Recent Developments
- 12.14 Sutter Health
- 12.14.1 Sutter Health Company Information
- 12.14.2 Sutter Health Business Overview
- 12.14.3 Sutter Health Revenue in Clinical Pathology Service Business (2021-2026)
- 12.14.4 Sutter Health Clinical Pathology Service Product Portfolio
- 12.14.5 Sutter Health Recent Developments
- 12.15 AmeriPath
- 12.15.1 AmeriPath Company Information
- 12.15.2 AmeriPath Business Overview
- 12.15.3 AmeriPath Revenue in Clinical Pathology Service Business (2021-2026)
- 12.15.4 AmeriPath Clinical Pathology Service Product Portfolio
- 12.15.5 AmeriPath Recent Developments
- 12.16 Biogenex
- 12.16.1 Biogenex Company Information
- 12.16.2 Biogenex Business Overview
- 12.16.3 Biogenex Revenue in Clinical Pathology Service Business (2021-2026)
- 12.16.4 Biogenex Clinical Pathology Service Product Portfolio
- 12.16.5 Biogenex Recent Developments
- 12.17 Cerba HealthCare Group
- 12.17.1 Cerba HealthCare Group Company Information
- 12.17.2 Cerba HealthCare Group Business Overview
- 12.17.3 Cerba HealthCare Group Revenue in Clinical Pathology Service Business (2021-2026)
- 12.17.4 Cerba HealthCare Group Clinical Pathology Service Product Portfolio
- 12.17.5 Cerba HealthCare Group Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst